Page 71 - boneArtis Seminare - Catalog

Synthacer® / Syntricer® Bone Void Filler
A mixture of 50:50% Synthacer® Ceraball® and Syntricer®Ceraball® may be bene cial, i.e. in the case of osteoporosis, providing a slower degradation of the ma- terial on the one hand and a mechanoindution of the newly formed lamellar bone on the other hand.
Loose lling of the defect achieves well-structured scaf- folds; it may be helpful to gently press a wet compress onto the defect and to oat the beads using a syringe with physiological solution in order to achieve a perfect lling of the cavity. When using injection device, any in- crease in pressure might cause an embolism has to be avoided.
Side E ects
General risks for use
Synthacer®/Syntricer® may only be inserted by trained surgeons.
Since Synthacer®/Syntricer® products are implants with- out an own defense mechanism, there is an imminent danger of contamination by hematongenous or intraop- erative infection.
As in all operations of the lower extremities, thrombo- embolism may be another common complication. In both these circumstances, an antibiotic prophylaxis and a thromboembolic prophylaxis, preferably using hepa- rin-based pharmaceuticals, is strongly recommended – at least during the non-weight bearing period a er the operation.
REV0118122017EN 71